Background: this is the 6th EMCDDA webinar on the Coronavirus. It will be exploring with the help of three experts from Northern, Central, Southern European EU countries (Finland, Greece and The Netherlands) whether the COVID-19 related emergency is having or is going to have any impact on Drugs Policy.
Researchers are increasingly expected to show that their work is policy relevant. What does that meant? What else are researchers competing with? Are there any rules that will help to be more sure that evidence based results catches the eye of policy makers?
This session will give you a realistic picture of:
This is a Continuing Professional Development (CPD) module and Knowledge Exchange Workshop currently hosted by the University of Stirling on behalf of SPECTRUM. It is convened by Dr Allison Ford and has been successfully delivered for over ten years at various of our partner Universities throughout the UK.
In the fourth week of June 2020 the 13th Nordic Public Health conference will take place in Iceland.
The theme of the conference is “Health and wellbeing for all – heading for the future”.
The conference is a platform for the Nordic countries to come together, share knowledge, experience and cultivate professional relationships and networks in the field of public health.
